Skip to content
Recall Observatory FDA recall evidence

Drug product

Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg), packaged in cartons containing 3 wallets of 28 Tablets each, Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United Stated, Manufactured by: Lupin Limited, Pithampur, (M.P.) - 454775, India, 244896, The individual wallet NDC 68180-904-11 and the carton NDC 68180-904-13.

D-0264-2022

November 19, 2021

Class III

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 89085
Status
Terminated
Classification
Class III
Quantity
4113 cartons
Official record key
drug-enforcement:D-0264-2022

Official wording

Reason: Subpotent Drug

Code information: Lot #: L000784 and L000785, Exp. Date May 2022

Distribution pattern: nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent